MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01404cam a2200361 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
BDZ0005652500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
StDuBDS |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190705172317.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
030908s2003 enka || 001 ||eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2003012876 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781588290977 : |
| Terms of availability |
£117.00 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1588290972 |
| Terms of availability |
0.00 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
Uk |
| -- |
StDuBDSZ |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.71 |
| Edition number |
21 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Pugsley, Michael K |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Cardiac drug development guide / |
| Statement of responsibility, etc. |
edited by Michael K. Pugsley. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Totowa, N.J. : |
| Name of publisher, distributor, etc. |
Humana Press ; |
| Place of publication, distribution, etc. |
[Oxford : |
| Name of publisher, distributor, etc. |
Blackwell] [distributor], |
| Date of publication, distribution, etc. |
c2003. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 431 p. : |
| Other physical details |
ill. ; |
| Dimensions |
26 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Methods in pharmacology and toxicology |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
This text provides an overview of the most current areas of therapeutic drug discovery in cardiac and cardiovascular medicine. It integrates academic, pharmaceutical and biotechnology perspectives for cardiac drug discovery. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cardiovascular agents. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug development. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cardiovascular Agents |
| General subdivision |
pharmacology |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Design |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Evaluation, Preclinical |
| General subdivision |
methods |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Pugsley, Michael K. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Methods in pharmacology and toxicology. |
| 887 #0 - NON-MARC INFORMATION FIELD |
|---|
| Content of non-MARC field |
Book |